Evusheld No Longer Authorized to Prevent COVID
Verywell / AstraZeneca Key Takeaways Evusheld is no longer authorized for use in the United States. What Is Evusheld? Evusheld is a combination of two monoclonal antibodies: tixagevimab and cilgavimab. Verywell / AstraZeneca Monoclonal antibodies bind to a specific site on the COVID virus to prevent it from getting into human cells. The drug was developed by AstraZeneca as pre-exposure prophylaxis for COVID. For the time being, no other monoclonals are authorized for COVID-19, Sullivan said....